Section Arrow
APLMW.NASDAQ
- Apollomics
Quotes are at least 15-min delayed:2024/12/24 13:00 EST
Last
 0.011949
-0.000551 (-4.41%)
Day High 
0.0138 
Prev. Close
0.0125 
1-M High
0.03 
Volume 
13.79K 
Bid
0.0092
Ask
0.0138
Day Low
0.01 
Open
0.013699 
1-M Low
0.0058 
Market Cap 
1.12M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.01 
20-SMA 0.01 
50-SMA 0.01 
52-W High 0.0436 
52-W Low 0.0052 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.34/-0.56
Enterprise Value
1.50M
Balance Sheet
Book Value Per Share
0.62
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.381-0.0221-5.48%-- 
CMNDClearmind Medicine1.68+0.46+37.70%0.16PE
CEROCERo Therapeutics Holdings0.06+0.0095+18.81%-- 
RXRXRecursion Pharmaceuticals7.23+0.24+3.43%-- 
CDTConduit Pharmaceuticals0.0576+0.0031+5.69%-- 
Quotes are at least 15-min delayed:2024/12/24 13:00 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.